The European Union's health regulator said on Wednesday it was reviewing French drugmaker Valneva's chikungunya vaccine after ...

Despite health authorities issuing fresh guidelines to tackle the growing threat of Chikungunya, action on the ground tells a ...

The country is considered the epicenter of the disease in the Americas, with epidemics reported over the years.

According to reports, a cause for concern is that 51 of the cases involve infants under one year of age, while 553 are among children under 18.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Bavarian Nordic’s Vimkunya (recombinant, adsorbed ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (1 May 2025) approved a vaccine (Vimkunya) used to ...

Pune: There were concerning complications seen in children during last year's chikungunya outbreak, including one case which ...

Maharashtra reported a significant rise in Chikungunya cases, increasing from 473 in early 2024 to 658 by April 2025. While other vector-borne diseases like malaria and dengue show a downward trend, ...

Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of the Advisory Committee on Immunization Practices.

Chikungunya is a mosquito-borne disease caused by the chikungunya virus. The most common symptoms of the infection are fever and joint pain. About 17 serious adverse events, including two deaths ...